The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
Open accessAbstract
The sonic hedgehog (Shh) signaling pathway is a major regulator of cell differentiation, cell proliferation, and tissue polarity. Aberrant activation of the Shh pathway has been shown in a variety of human cancers, including, basal cell carcinoma, malignant gliomas, medulloblastoma, leukemias, and cancers of the breast, lung, pancreas, and prostate. Tumorigenesis, tumor progression and therapeutic response have all been shown to be impacted by the Shh signaling pathway. Downstream effectors of the Shh pathway include smoothened (SMO) and glioma-associated oncogene homolog (GLI) family of zinc finger transcription factors. Both are regarded as important targets for cancer therapeutics. While most efforts have been devoted towards pharmacologically targeting SMO, developing GLI-targeted approach has its merit because of the fact that GLI proteins can be activated by both Shh ligand-dependent and -independent mechanisms. To date, two SMO inhibitors (LDE225/Sonidegib and GDC-0449/Vismodegib) have received FDA approval for treating basal cell carcinoma while many clinical trials are being conducted to evaluate the efficacy of this exciting class of targeted therapy in a variety of cancers. In this review, we provide an overview of the biology of the Shh pathway and then detail the current landscape of the Shh-SMO-GLI pathway inhibitors including those in preclinical studies and clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Mutations affecting segment number and polarity in Drosophila
Nüsslein-Volhard, C., & Wieschaus, E. (1980) · Nature · doi:10.1038/287795a0 · Cited by 4,370
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Hedgehog signaling in animal development: paradigms and principles
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 2,985
Grothey, A., Cutsem, E. V., Sobrero, A., Siena, S., Falcone, A., Ychou, M., Humblet, Y., Bouché, O., Mineur, L., Barone, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61900-x · Cited by 2,895 · cited 1×
“Regorafenib (Stivarga) Bayer VEGFR1-3 [170] PDGFRβ FGFR-1 KIT RET B-Raf Metastatic Colorectal Cancer [171] Metastatic Gastrointestinal Stromal Tumors [172]”
BackgroundDemetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
Sternberg, C. N., Davis, I. D., Mardiak, J., Szczylik, C., Lee, E., Wagstaff, J., Barrios, C. H., Salman, P., Gladkov, O. A., Kavina, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9764 · Cited by 2,471
Wilke, H., Muro, K., Van Cutsem, E., Oh, S.-C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O., Kim, T.-Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70420-6 · Cited by 2,438
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Oudard, S., Negrier, S., Szczylik, C., Pili, R., Bjarnason, G. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1293 · Cited by 2,181
Echelard, Y., Epstein, D. J., St-Jacques, B., Shen, L., Mohler, J., McMahon, J. A., & McMahon, A. P. (1993) · Cell · doi:10.1016/0092-8674(93)90627-3 · Cited by 2,154
van der Graaf, W. T., Blay, J.-Y., Chawla, S. P., Kim, D.-W., Bui-Nguyen, B., Casali, P. G., Schöffski, P., Aglietta, M., Staddon, A. P., Beppu, Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60651-5 · Cited by 2,102
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome
Hahn, H., Wicking, C., Zaphiropoulos, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A. B., Gillies, S., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81268-4 · Cited by 2,022
St-Jacques, B., Hammerschmidt, M., & McMahon, A. P. (1999) · Genes & Development · doi:10.1101/gad.13.16.2072 · Cited by 1,735
Altered Neural Cell Fates and Medulloblastoma in Mouse patched Mutants
Goodrich, L. V., Milenković, L., Higgins, K. M., & Scott, M. P. (1997) · Science · doi:10.1126/science.277.5329.1109 · Cited by 1,696
Brose, M. S., Nutting, C. M., Jarzab, B., Elisei, R., Siena, S., Bastholt, L., de la Fouchardiere, C., Pacini, F., Paschke, R., Shong, Y. K., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60421-9 · Cited by 1,663
Wells, S. A., Robinson, B. G., Gagel, R. F., Dralle, H., Fagin, J. A., Santoro, M., Baudin, E., Elisei, R., Jarzab, B., Vasselli, J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5040 · Cited by 1,559
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts, D. J., Lauwers, G. Y., Qi, Y. P., Gysin, S., Castillo, C. F.-D., Yajnik, V., et al. (2003) · Nature · doi:10.1038/nature02009 · Cited by 1,480
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
Chen, J. K., Taipale, J., Cooper, M. K., & Beachy, P. A. (2002) · Genes & Development · doi:10.1101/gad.1025302 · Cited by 1,465
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,464
Wilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Demetri, G. D., Reichardt, P., Kang, Y.-K., Blay, J.-Y., Rutkowski, P., Gelderblom, H., Hohenberger, P., Leahy, M., von Mehren, M., Joensuu, H., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61857-1 · Cited by 1,406
Van Cutsem, E., Tabernero, J., Lakomy, R., Prenen, H., Prausová, J., Macarulla, T., Ruff, P., van Hazel, G. A., Moiseyenko, V., Ferry, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.8201 · Cited by 1,402
Wilhelm, S. M., Dumas, J., Adnane, L., Lynch, M., Carter, C. A., Schütz, G., Thierauch, K., & Zopf, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.25864 · Cited by 1,355 · cited 1×
“Regorafenib (Stivarga) Bayer VEGFR1-3 [170] PDGFRβ FGFR-1 KIT RET B-Raf Metastatic Colorectal Cancer [171] Metastatic Gastrointestinal Stromal Tumors [172]”
BackgroundYakes, F. M., Chen, J., Tan, J., Yamaguchi, K., Shi, Y., Yu, P., Qian, F., Chu, F., Bentzien, F., Cancilla, B., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0264 · Cited by 1,336
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
Taipale, J., Chen, J. K., Cooper, M. K., Wang, B., Mann, R. K., Milenkovic, L., Scott, M. P., & Beachy, P. A. (2000) · Nature · doi:10.1038/35023008 · Cited by 1,311
Garon, E. B., Ciuleanu, T.-E., Arrieta, O., Prabhash, K., Syrigos, K. N., Goksel, T., Park, K., Gorbunova, V., Kowalyszyn, R. D., Pikiel, J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60845-x · Cited by 1,309 · cited 1×
“Ramucirumab (Cyramza) Eli Lilly VEGFR2 [181] Gastric Adenocarcinoma [182] Gastro-Esophageal Junction Adenocarcinoma [182] Metastatic Non-Small-Cell Lung Cancer [183]”
BackgroundHedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem Cells
Liu, S., Dontu, G., Mantle, I. D., Patel, S., Ahn, N.-S., Jackson, K. W., Suri, P., & Wicha, M. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0054 · Cited by 1,244
Hedgehog: functions and mechanisms
Varjosalo, M., & Taipale, J. (2008) · Genes & Development · doi:10.1101/gad.1693608 · Cited by 1,217
Cabozantinib in Progressive Medullary Thyroid Cancer
Elisei, R., Schlumberger, M. J., Müller, S. P., Schöffski, P., Brose, M. S., Shah, M. H., Licitra, L., Jarzab, B., Medvedev, V., Kreissl, M. C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4659 · Cited by 1,217
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
Watkins, D. N., Berman, D. M., Burkholder, S. G., Wang, B., Beachy, P. A., & Baylin, S. B. (2003) · Nature · doi:10.1038/nature01493 · Cited by 1,082
Krauss, S., Concordet, J.-P., & Ingham, P. W. (1993) · Cell · doi:10.1016/0092-8674(93)90628-4 · Cited by 1,070
Multiple Nevoid Basal-Cell Epithelioma, Jaw Cysts and Bifid Rib: A Syndrome
Gorlin, R. J., & Goltz, R. W. (1960) · New England Journal of Medicine · doi:10.1056/nejm196005052621803 · Cited by 1,029
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
Rudin, C. M., Hann, C. L., Laterra, J., Yauch, R. L., Callahan, C. A., Fu, L., Holcomb, T., Stinson, J., Gould, S. E., Coleman, B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902903 · Cited by 1,019
Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome
Kimonis, V. E., Goldstein, A. M., Pastakia, B., Yang, M. L., Kase, R., DiGiovanna, J. J., Bale, A. E., & Bale, S. J. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970331)69:3<299::aid-ajmg16>3.0.co;2-m · Cited by 1,010
A paracrine requirement for hedgehog signalling in cancer
Yauch, R. L., Gould, S. E., Scales, S. J., Tang, T., Tian, H., Ahn, C. P., Marshall, D., Fu, L., Januario, T., Kallop, D., et al. (2008) · Nature · doi:10.1038/nature07275 · Cited by 961
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
Karhadkar, S. S., Steven Bova, G., Abdallah, N., Dhara, S., Gardner, D., Maitra, A., Isaacs, J. T., Berman, D. M., & Beachy, P. A. (2004) · Nature · doi:10.1038/nature02962 · Cited by 950
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Zhao, C., Chen, A., Jamieson, C. H., Fereshteh, M., Abrahamsson, A., Blum, J., Kwon, H. Y., Kim, J., Chute, J. P., Rizzieri, D., et al. (2009) · Nature · doi:10.1038/nature07737 · Cited by 869
Roelink, H., Augsburger, A., Heemskerk, J., Korzh, V., Norlin, S., Ruiz i Altaba, A., Tanabe, Y., Placzek, M., Edlund, T., Jessell, T. M., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90514-2 · Cited by 854
Teratogen-Mediated Inhibition of Target Tissue Response to Shh Signaling
Cooper, M. K., Porter, J. A., Young, K. E., & Beachy, P. A. (1998) · Science · doi:10.1126/science.280.5369.1603 · Cited by 848
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
The Hedgehog Response Network: Sensors, Switches, and Routers
Lum, L., & Beachy, P. A. (2004) · Science · doi:10.1126/science.1098020 · Cited by 838
Basal cell carcinomas: attack of the hedgehog
Epstein, E. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2503 · Cited by 834
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., Chen, J. K., Cooper, M. K., Taipale, J., Olson, J. M., et al. (2002) · Science · doi:10.1126/science.1073733 · Cited by 803
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Lauth, M., Bergström, Å., Shimokawa, T., & Toftgård, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609699104 · Cited by 782
Kool, M., Koster, J., Bunt, J., Hasselt, N. E., Lakeman, A., van Sluis, P., Troost, D., Meeteren, N. S.-V., Caron, H. N., Cloos, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003088 · Cited by 722
Sasaki, H., Nishizaki, Y., Hui, C.-C., Nakafuku, M., & Kondoh, H. (1999) · Development · doi:10.1242/dev.126.17.3915 · Cited by 715
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
Oro, A. E., Higgins, K. M., Hu, Z., Bonifas, J. M., Epstein, E. H., & Scott, M. P. (1997) · Science · doi:10.1126/science.276.5313.817 · Cited by 710
Feldmann, G., Dhara, S., Fendrich, V., Bedja, D., Beaty, R., Mullendore, M., Karikari, C., Alvarez, H., Iacobuzio-Donahue, C., Jimeno, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3281 · Cited by 694
Gli Proteins in Development and Disease
Hui, C.-C., & Angers, S. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154048 · Cited by 693
The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic hedgehog signal transduction
Incardona, J. P., Gaffield, W., Kapur, R. P., & Roelink, H. (1998) · Development · doi:10.1242/dev.125.18.3553 · Cited by 656
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy
Scales, S. J., & de Sauvage, F. J. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.007 · Cited by 650
Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma
Bar, E. E., Chaudhry, A., Lin, A., Fan, X., Schreck, K., Matsui, W., Piccirillo, S., Vescovi, A. L., DiMeco, F., Olivi, A., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0166 · Cited by 607
Catenacci, D. V. T., Junttila, M. R., Karrison, T., Bahary, N., Horiba, M. N., Nattam, S. R., Marsh, R., Wallace, J., Kozloff, M., Rajdev, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.8719 · Cited by 561 · cited 1×
“Preclinical data showed that SMO inhibition could deplete the tumor stroma; however, a Phase Ib/II trial comparing gemcitabine in combination with vismodegib to gemcitabine with placebo for pancreatic ductal adenocarcinoma (PDAC) was terminated early because it did not meet the criteria for futility [84,85].”
BackgroundDesert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis
Yao, H. H.-C., Whoriskey, W., & Capel, B. (2002) · Genes & Development · doi:10.1101/gad.981202 · Cited by 537
Stecca, B., Mas, C., Clement, V., Zbinden, M., Correa, R., Piguet, V., Beermann, F., & Ruiz i Altaba, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700776104 · Cited by 530
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Shih, T., & Lindley, C. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.11.015 · Cited by 521
Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
Dierks, C., Beigi, R., Guo, G.-R., Zirlik, K., Stegert, M. R., Manley, P., Trussell, C., Schmitt-Graeff, A., Landwerlin, K., Veelken, H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.003 · Cited by 517
Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling
Sanchez, P., Hernández, A. M., Stecca, B., Kahler, A. J., DeGueme, A. M., Barrett, A., Beyna, M., Datta, M. W., Datta, S., & Ruiz i Altaba, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404956101 · Cited by 514
Frank-Kamenetsky, M., Zhang, X. M., Bottega, S., Guicherit, O., Wichterle, H., Dudek, H., Bumcrot, D., Wang, F. Y., Jones, S., Shulok, J., et al. (2002) · Journal of Biology · doi:10.1186/1475-4924-1-10 · Cited by 488
Mammalian Suppressor-of-Fused modulates nuclear–cytoplasmic shuttling of GLI-1
Kogerman, P., Grimm, T., Kogerman, L., Krause, D., Undén, A. B., Sandstedt, B., Toftgård, R., & Zaphiropoulos, P. G. (1999) · Nature Cell Biology · doi:10.1038/13031 · Cited by 476
Tohyama, O., Matsui, J., Kodama, K., Hata-Sugi, N., Kimura, T., Okamoto, K., Minoshima, Y., Iwata, M., & Funahashi, Y. (2014) · Journal of Thyroid Research · doi:10.1155/2014/638747 · Cited by 475
Structure of the human smoothened receptor bound to an antitumour agent
Wang, C., Wu, H., Katritch, V., Han, G. W., Huang, X.-P., Liu, W., Siu, F. Y., Roth, B. L., Cherezov, V., & Stevens, R. C. (2013) · Nature · doi:10.1038/nature12167 · Cited by 464
Varnat, F., Duquet, A., Malerba, M., Zbinden, M., Mas, C., Gervaz, P., & Ruiz i Altaba, A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900039 · Cited by 463
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Rasheed, Z. A., Yang, J., Wang, Q., Kowalski, J., Freed, I., Murter, C., Hong, S.-M., Koorstra, J.-B., Rajeshkumar, N. V., He, X., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp535 · Cited by 437
Regulation of pancreas development by hedgehog signaling
Hebrok, M., Kim, S. K., St-Jacques, B., McMahon, A. P., & Melton, D. A. (2000) · Development · doi:10.1242/dev.127.22.4905 · Cited by 412
Hedgehog Signaling Pathway is a New Therapeutic Target for Patients with Breast Cancer
Kubo, M., Nakamura, M., Tasaki, A., Yamanaka, N., Nakashima, H., Nomura, M., Kuroki, S., & Katano, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0416 · Cited by 399
The Hedgehog's tale: developing strategies for targeting cancer
Ng, J. M. Y., & Curran, T. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3079 · Cited by 398
GDC-0449—A potent inhibitor of the hedgehog pathway
Robarge, K. D., Brunton, S. A., Castanedo, G. M., Cui, Y., Dina, M. S., Goldsmith, R., Gould, S. E., Guichert, O., Gunzner, J. L., Halladay, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.049 · Cited by 386
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., Tsui, V., Durham, A. B., Dlugosz, A. A., Haverty, P. M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.001 · Cited by 382
Chen, M.-H., Li, Y.-J., Kawakami, T., Xu, S.-M., & Chuang, P.-T. (2004) · Genes & Development · doi:10.1101/gad.1185804 · Cited by 368
Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
Sitohy, B., Nagy, J. A., & Dvorak, H. F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3406 · Cited by 360
Beauchamp, E. M., Ringer, L., Bulut, G., Sajwan, K. P., Hall, M. D., Lee, Y.-C., Peaceman, D., Özdemirli, M., Rodriguez, O., Macdonald, T. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42874 · Cited by 351
Kim, J., Kato, M., & Beachy, P. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912180106 · Cited by 344
Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer
久保, 真. (2005) · Medical Entomology and Zoology · Cited by 342
Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
Pan, S., Wu, X., Jiang, J., Gao, W., Wan, Y., Cheng, D., Han, D., Liu, J., Englund, N. P., Wang, Y., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1000307 · Cited by 325
Novel Lipid Modifications of Secreted Protein Signals
Mann, R. K., & Beachy, P. A. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073933 · Cited by 322
Lee, K.-R., Kozukue, N., Han, J.-S., Park, J.-H., Chang, E.-Y., Baek, E.-J., Chang, J.-S., & Friedman, M. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030526d · Cited by 312
Aszterbaum, M., Rothman, A., Fisher, M., Xie, J., Bonifas, J. M., Zhang, X., Epstein, E. H., Johnson, R. L., & Scott, M. P. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00222.x · Cited by 306
Kim, J., Lee, J. J., Kim, J., Gardner, D., & Beachy, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006822107 · Cited by 304
Williams, J. A., Guicherit, O. M., Zaharian, B. I., Xu, Y., Chai, L., Wichterle, H., Kon, C., Gatchalian, C., Porter, J. A., Rubin, L. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0732813100 · Cited by 299
Characterization of two patched receptors for the vertebrate hedgehog protein family
Carpenter, D., Stone, D. M., Brush, J., Ryan, A., Armanini, M., Frantz, G., Rosenthal, A., & de Sauvage, F. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13630 · Cited by 289
Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog
Fan, H., Oro, A. E., Scott, M. P., & Khavari, P. A. (1997) · Nature Medicine · doi:10.1038/nm0797-788 · Cited by 276
Hedgehog regulates smoothened activity by inducing a conformational switch
Zhao, Y., Tong, C., & Jiang, J. (2007) · Nature · doi:10.1038/nature06225 · Cited by 274
Hhat Is a Palmitoylacyltransferase with Specificity for N-Palmitoylation of Sonic Hedgehog
Buglino, J. A., & Resh, M. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803901200 · Cited by 264
Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
Tremblay, M. R., Lescarbeau, A., Grogan, M. J., Tan, E., Lin, G., Austad, B. C., Yu, L.-C., Behnke, M. L., Nair, S. J., Hagel, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900305z · Cited by 252
Context-dependent Regulation of the GLI Code in Cancer by HEDGEHOG and Non-HEDGEHOG Signals
Stecca, B., & Ruiz i Altaba, A. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp052 · Cited by 252
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
Stecca, B., & Ruiz i Altaba, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.16 · Cited by 233
Comparative biological responses to human Sonic, Indian, and Desert hedgehog
Pathi, S., Pagan-Westphal, S., Baker, D. P., Garber, E. A., Rayhorn, P., Bumcrot, D., Tabin, C. J., Blake Pepinsky, R., & Williams, K. P. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00427-0 · Cited by 223
Cheng, S. Y., & Bishop, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082096999 · Cited by 221
The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
Kieran, M. W., Kalluri, R., & Cho, Y.-J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006593 · Cited by 206
Catching a Gli-mpse of Hedgehog
Ruiz i Altaba, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80325-6 · Cited by 198
Ramaswamy, B., Lu, Y., Teng, K.-Y., Nuovo, G., Li, X., Shapiro, C. L., & Majumder, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1248 · Cited by 191
Regulation of Gli1 Transcriptional Activity in the Nucleus by Dyrk1
Mao, J., Maye, P., Kogerman, P., Tejedor, F. J., Toftgard, R., Xie, W., Wu, G., & Wu, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206743200 · Cited by 190
Bevacizumab: A Review of Its Use in Advanced Cancer
Keating, G. M. (2014) · Drugs · doi:10.1007/s40265-014-0302-9 · Cited by 177
Frequent requirement of hedgehog signaling in non-small cell lung carcinoma
Yuan, Z., Goetz, J. A., Singh, S., Ogden, S. K., Petty, W. J., Black, C. C., Memoli, V. A., Dmitrovsky, E., & Robbins, D. J. (2007) · Oncogene · doi:10.1038/sj.onc.1209860 · Cited by 174
Hedgehog Fights Back: Mechanisms of Acquired Resistance against Smoothened Antagonists
Metcalfe, C., & de Sauvage, F. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0923 · Cited by 168
Axitinib for the Management of Metastatic Renal Cell Carcinoma
Escudier, B. J., & Gore, M. E. (2011) · Drugs in R&D · doi:10.2165/11591240-000000000-00000 · Cited by 165
Sagiv, E., Starr, A., Rozovski, U., Khosravi, R., Altevogt, P., Wang, T., & Arber, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6463 · Cited by 163
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened
Munchhof, M. J., Li, Q., Shavnya, A., Borzillo, G. V., Boyden, T. L., Jones, C. S., LaGreca, S. D., Martinez-Alsina, L., Patel, N., Pelletier, K., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml2002423 · Cited by 162
Aberger, F., & Altaba, A. R. I. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.05.003 · Cited by 160
Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling
Petrova, E., Rios-Esteves, J., Ouerfelli, O., Glickman, J. F., & Resh, M. D. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1184 · Cited by 160
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
Pricl, S., Cortelazzi, B., Col, V. D., Marson, D., Laurini, E., Fermeglia, M., Licitra, L. F., Pilotti, S., Bossi, P., & Perrone, F. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.09.003 · Cited by 155
A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion
Lo, H., Zhu, H., Cao, X., Aldrich, A. J., & Ali‐Osman, F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0886 · Cited by 153
Self-citationPI-88 and Novel Heparan Sulfate Mimetics Inhibit Angiogenesis
Ferro, V., Dredge, K. S., Liu, L., Hammond, E., Bytheway, I., Li, C., Johnstone, K. D., Karoli, T., Davis, K., Copeman, E., et al. (2007) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-982088 · Cited by 150
Ferro, V., Liu, L., Johnstone, K. D., Wimmer, N., Karoli, T., Handley, P., Rowley, J. A., Dredge, K. S., Li, C. P., Hammond, E., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201708h · Cited by 146
Sánchez‐Gómez, P., & Altaba, A. R. I. (2004) · Mechanisms of Development · doi:10.1016/j.mod.2004.10.002 · Cited by 146
Cao, X., Geradts, J., Dewhirst, M. W., & Lo, H. (2011) · Oncogene · doi:10.1038/onc.2011.219 · Cited by 139
Self-citationCombined activities of hedgehog signaling inhibitors regulate pancreas development
Kawahira, H., Nancy, H., Tzanakakis, E. S., McMahon, A. P., Chuang, P., & Hebrok, M. (2003) · Development · doi:10.1242/dev.00653 · Cited by 135
The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis
Rajurkar, M., Jesus-Monge, W. E. D., Driscoll, D. R., Appleman, V. A., Huang, H., Cotton, J. L., Klimstra, D. S., Zhu, L. J., Simin, K. J., Xu, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114168109 · Cited by 129
Seto, M., Ohta, M., Asaoka, Y., Ikenoue, T., Tada, M., Miyabayashi, K., Mohri, D., Tanaka, Y., Ijichi, H., Tateishi, K., et al. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20516 · Cited by 127
Sheng, T., Chi, S., Zhang, X., & Xie, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500300200 · Cited by 125
Wickström, M., Dyberg, C. H., Shimokawa, T., Milosevic, J., Baryawno, N., Fuskevåg, O., Larsson, R. L., Kogner, P., Zaphiropoulos, P. G., & Johnsen, J. I. (2012) · International Journal of Cancer · doi:10.1002/ijc.27820 · Cited by 125
Nanta, R., Kumar, D., Meeker, D. G., Rodova, M., Veldhuizen, P. J. V., Shankar, S., & Srivastava, R. K. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.5 · Cited by 122
Hedgehog pathway and GLI1 isoforms in human cancer.
Carpenter, R. L., & Lo, H. (2012) · PubMed · Cited by 121
Self-citationPaces-Fessy, M., BOUCHER, D., Petit, E., PAUTE-BRIAND, S., & Blanchet-Tournier, M.-F. (2004) · Biochemical Journal · doi:10.1042/bj20030786 · Cited by 118
Gross‐Goupil, M., Françlois, L., Quivy, A., & Ravaud, A. (2013) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s10594 · Cited by 116
Opportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes
List, A. F., Beran, M., DiPersio, J. F., Slack, J. L., Vey, N., Rosenfeld, C. S., & Greenberg, P. L. (2003) · Leukemia · doi:10.1038/sj.leu.2403021 · Cited by 115
Wilson, C. W., Chen, M.-H., & Chuang, P.-T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005182 · Cited by 112
Fu, J., Rodova, M., Nanta, R., Meeker, D., Veldhuizen, P. J. V., Srivastava, R. K., & Shankar, S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not011 · Cited by 112
The potential of heparanase as a therapeutic target in cancer
Pisano, C., Vlodavsky, I., Ilan, N., & Zunino, F. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.010 · Cited by 109
Zhou, J., Zhu, G., Huang, J. X., Li, L., Du, Y., Gao, Y., Wu, D., Wang, X., Hsieh, J., He, D., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.006 · Cited by 107
GLI2 inhibition abrogates human leukemia stem cell dormancy
Sadarangani, A., Pineda, G., Lennon, K. M., Chun, H.-J. E., Shih, A. Y., Schairer, A., Court, A. C., Goff, D. J., Prashad, S., Geron, I., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0453-9 · Cited by 106
Smoothened as a new therapeutic target for human osteosarcoma
Hirotsu, M., Setoguchi, T., Sasaki, H., Matsunoshita, Y., Gao, H., Nagao, H., Kunigou, O., & Komiya, S. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-5 · Cited by 106
Distinct roles of PTCH2 splice variants in Hedgehog signalling
Rahnama, F., Toftgård, R., & Zaphiropoulos, P. G. (2004) · Biochemical Journal · doi:10.1042/bj20031200 · Cited by 101
Krupitskaya, Y., & Wakelee, H. A. (2009) · PubMed · Cited by 98
Srivastava, R. K., Zaid‐Kaylani, S., Edrees, N., Li, C., Talwelkar, S. S., Xu, J., Palle, K., Pressey, J. G., & Athar, M. (2014) · Oncotarget · doi:10.18632/oncotarget.2569 · Cited by 92
Chen, Q., Xu, R., Zeng, C., Lu, Q., Huang, D., Shi, C., Zhang, W., Deng, L., Yan, R., Rao, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088386 · Cited by 87
Zhang, K., Sun, C., Zhang, Q., & Xiaojing, W. (2014) · Medical Oncology · doi:10.1007/s12032-014-0368-y · Cited by 85
Salnikov, A. V., Bretz, N. P., Perne, C., Hazin, J., Keller, S., Fogel, M., Herr, I., Schlange, T., Moldenhauer, G., & Altevogt, P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.102 · Cited by 81
Ostapoff, K. T., Awasthi, N., Cenik, B. K., Hinz, S., Dredge, K. S., Schwarz, R. E., & Brekken, R. A. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1123 · Cited by 74
Nakamura, S., Nagano, S., Nagao, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069466 · Cited by 73
Ohashi, T., Oguro, Y., Tanaka, T., Shiokawa, Z., Tanaka, Y., Shibata, S., Sato, Y., Yamakawa, H., Hattori, H., Yamamoto, Y., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.07.034 · Cited by 72
Tang, T., Tang, J. Y., Li, D., Reich, M., Callahan, C. A., Fu, L., Yauch, R. L., Wang, F., Kotkow, K. J., Chang, K. S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3370 · Cited by 71
The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth
Zhu, H., Carpenter, R. L., Han, W., & Lo, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.014 · Cited by 70
Self-citationYou, M., Varona-Santos, J., Singh, S., Robbins, D. J., Savaraj, N., & Nguyen, D. M. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.08.035 · Cited by 69
Ziv-aflibercept in metastatic colorectal cancer
Sun, W., & Patel, A. K. (2013) · Biologics · doi:10.2147/btt.s39360 · Cited by 69
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Liu, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11384 · Cited by 69
Synthesis and anticancer activity studies of cyclopamine derivatives
Zhang, J., Garrossian, M., Gardner, D. R., Garrossian, A., Chang, Y., Kim, Y. K., & Chang, C. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.017 · Cited by 67
Hoch, L., Faure, H., Roudaut, H., Schoenfelder, A., Mann, A., Girard, N., Bihannic, L., Ayrault, O., Petricci, E., Taddei, M., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-267849 · Cited by 65
Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma
Petrova, E. P., Matevossian, A., & Resh, M. D. (2014) · Oncogene · doi:10.1038/onc.2013.575 · Cited by 62
Nye, M. D., Almada, L. L., Fernández‐Barrena, M. G., Marks, D. L., Elsawa, S. F., Vrabel, A. M., Tolosa, E. J., Ellenrieder, V., & Fernández-Zapico, M. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.545194 · Cited by 61
Andrae, N., Kirches, E., Hartig, R., Haase, D., Keilhoff, G., Kalinski, T., & Mawrin, C. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.01.032 · Cited by 58
Mimeault, M., Johansson, S. L., Hénichart, J., Depreux, P., & Batra, S. K. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1013 · Cited by 58
Han, J.-B., Sang, F., Chang, J.-J., Hua, Y.-Q., Shi, W.-D., Tang, L.-H., & Liu, L.-M. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s49148 · Cited by 56
Deng, W., Vanderbilt, D. B., Lin, C., Martin, K. H., Brundage, K. M., & Ruppert, J. M. (2015) · Journal of Cell Science · doi:10.1242/jcs.162164 · Cited by 55
Rohner, A. K., Spilker, M. E., Lam, J. L., Pascual, B., Bartkowski, D. M., Li, Q. J., Yang, A. H., Stevens, G., Xu, M., Wells, P. A., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0691 · Cited by 53
Carpenter, R. L., Paw, I., Zhu, H., Sirkisoon, S. R., Xing, F., Watabe, K., Debinski, W., & Lo, H. (2015) · Oncotarget · doi:10.18632/oncotarget.4248 · Cited by 52
Self-citationMatevossian, A., & Resh, M. D. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0345-x · Cited by 50
Ibuki, N., Ghaffari, M., Pandey, M., Iu, I., Fazli, L., Kashiwagi, M., Tojo, H., Nakanishi, O., Gleave, M. E., & Cox, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28193 · Cited by 50
Wang, W., Li, Q., Yang, Z., Duan, L., Yu, K., Zhang, L., Li, Y., Cai, X., Shen, T., & Xiong, W. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s71034 · Cited by 48
Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer
Zhang, L., Ngo, J. A., Wetzel, M. D., & Marchetti, D. (2015) · Neoplasia · doi:10.1016/j.neo.2014.11.007 · Cited by 48
Inoue, K., Torimura, T., Nakamura, T., Iwamoto, H., Masuda, H., Abe, M., Hashimoto, O., Koga, H., Ueno, T., Yano, H., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2041 · Cited by 45
Kerl, K., Moreno, N., Holsten, T., Ahlfeld, J., Mertins, J., Hotfilder, M., Kool, M., Bartelheim, K., Schleicher, S., Handgretinger, R., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28719 · Cited by 43
Ishii, T., Shimizu, Y., Nakashima, K., Kondo, S., Ogawa, K., Sasaki, S., & Matsui, H. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.014 · Cited by 42
Coon, V. C., Laukert, T., Pedone, C. A., Laterra, J., Kim, K. J., & Fults, D. W. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0486 · Cited by 41
Tojo, M., Kiyosawa, H., Iwatsuki, K., & Kaneko, F. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04583.x · Cited by 38
Yoon, J. W., Lamm, M. L. G., Iannaccone, S., Higashiyama, N., Leong, K.-F., Iannaccone, P. M., & Walterhouse, D. O. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.06.006 · Cited by 35
Chang, Q., Foltz, W. D., Chaudary, N., Hill, R. P., & Hedley, D. W. (2012) · International Journal of Cancer · doi:10.1002/ijc.28006 · Cited by 35
Makinodan, E., & Marneros, A. G. (2012) · Experimental Dermatology · doi:10.1111/exd.12016 · Cited by 33
Shahi, M. H., Holt, R., & Rebhun, R. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096593 · Cited by 31
Zhang, Z., Hua, R., Zhang, J., Zhao, W., Zhao, E., Tu, L., Wang, C., Cao, H., & Zhang, Z. (2015) · Europe PMC (PubMed Central) · Cited by 26
Burgos-Ojeda, D., McLean, K., Bai, S., Pulaski, H. L., Gong, Y., da Silva, I. S., Skorecki, K. L., Tzukerman, M., & Buckanovich, R. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2845 · Cited by 17
Han, W., Carpenter, R. L., & Lo, H. (2013) · Cancer Hallmarks · doi:10.1166/ch.2013.1006 · Cited by 13
Self-citation
Cited by
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Sriram, K., & Insel, P. A. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111062 · Cited by 1,258
Stem cell fate in cancer growth, progression and therapy resistance
Lytle, N. K., Barber, A. G., & Reya, T. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0056-x · Cited by 647
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Müller, H. L., Merchant, T. E., Warmuth-Metz, M., Martinez-Barbera, J.-P., & Puget, S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0125-9 · Cited by 515
A highlight on Sonic hedgehog pathway
Carballo, G. B., Honorato, J. R., de Lopes, G. P. F., & Spohr, T. C. L. D. S. E. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0220-7 · Cited by 460
Metadata
- Authors
- Rimkus, T., Carpenter, R., Qasem, S., Chan, M., & Lo, H.-W.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2016-02-15
- Volume
- 8
- Issue
- 2
- Pages
- 22
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2269814587
- Cited by
- 581
- References
- 168
- FWCI
- 37.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.